comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 00:35:52 - browse：852

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： PBMs drew scrutiny in House hearing — and so did pharma

WSS

Trans patients at the end of life deserve respect and dignity

Why the quest to eradicate polio has stumbled

Akili changes sales model for its ADHD video game treatment

Patients, doctors press FTC to beef up hospital merger scrutiny

Fed up with FDA, ALS advocates consider a take

Health officials lay out plans to cope with respiratory virus season

knowledge

comprehensive

focus

Hepatitis C has a cure — but many Americans still lack access to it

Why the quest to eradicate polio has stumbled

In age of alternative facts, a scholarly course on calling out crap

Can U.S. cancer drug shortages be fixed?

Guidelines to prevent youth baseball injuries need more muscle

FDA greenlights medical device to combat bladder issues

Walensky prepares to leave CDC — and Congress — behind

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Drug repurposing or repositioning? The language matters

White House Covid adviser calls on docs to combat misinformation

focus

'A game

Transgender sports debate: Physicians say bans are health issue

Fed up with FDA, ALS advocates consider a take

Senate bill would ban some hospital facility fees

Fed up with FDA, ALS advocates consider a take

Former Pear Therapeutics executives start new VC firm

explore

leisure time

hotspot

leisure time